Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Pangraf 0.03% Ointment
Manufacturer/Marketed By : MANKIND PHARMACEUTICALS LIMITED
$1.83 $1.56
Pangraf 0.03% Ointment contains the active substance Tacrolimus. It is an immunosuppressant that belongs to the class of medications called calcineurin inhibitors. It is used to treat moderate to severe...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
TACROLIMUS
Active Pharmaceutical Ingredient
Pangraf 0.03% Ointment
1,83$
1,56$
Pangraf 0.03% Ointment contains the active substance Tacrolimus. It is an immunosuppressant that belongs to the class of medications called calcineurin inhibitors. It is used to treat moderate to severe atopic dermatitis (eczema) in adults who cannot use other medications for their condition or whose eczema has not responded to other medications. It suppresses the immune system from producing substances that may develop eczema. Do not take this Pangraf 0.03% Tube Of 10gm Ointment if you are allergic to tacrolimus or any of the other ingredients of this medicine. Report your physician if you are allergic to any antibiotic group. Inform your doctor if you have or had a liver failure, skin problems or skin cancer, or a weakened immune system. Notify your physician immediately if you develop fever, bruising under the skin (which may appear as red dots), unexplained tiredness, confusion, yellowing of the skin or eyes, reduced urine output, vision loss, and seizures after taking this medicine. Limit exposure to sunlight and UV light while consuming Pangraf 0.03% Ointment by wearing appropriate protective clothing and sunscreen with a high sun protection factor. This is because of the potential risk of malignant skin changes with immunosuppressive therapy. Do not apply this ointment to the infected areas if you have infected lesions. If you notice any change in the appearance of your skin, consult your physician immediately. This medicine is not approved for children younger than 16 years of age.
Active Pharmaceutical Ingredient
Uses
• Moderate to severe atopic dermatitis (eczema)
Benefits
Pangraf 0.03% Ointment 10gm provides immunosuppression by inhibiting T-lymphocyte activation and proliferation and T-helper-cell-dependent B-cell response. It works by attaching to a protein called FKBP-12 and forms a complex called tacrolimus-FKBP, which inhibits the action of calcineurin phosphatase. This, in turn, inhibits the formation of T cells and suppresses the immune response.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Acne
• Facial redness
• Eye infections
• Lentigo (flat brown spots on the skin)
• Cold sores
• Swelling of the hands, arms, feet, ankles, or lower legs
Common Side Effects
• Burning sensation and itching
• Redness, feeling or warmth
• Pain
• Increased skin sensitivity to hot and cold
• Skin tingling
• Rash
How To Use
This medicine is only for topical use. Always use Pangraf Ointment exactly as advised by your doctor. Apply the ointment as a thin layer to the affected areas of your skin. Avoid using the ointment inside your nose, mouth, or eyes. Before using the ointment, be sure your skin is completely dry. Your doctor will say the exact amount and time you should use this ointment. If you accidentally swallowed the ointment, contact your physician immediately and seek medical advice.
Safety Advice
• Breast Feeding: Do not consume Pangraf 0.03% Ointment if you are breastfeeding because this medicine is excreted into breast milk and may cause harmful effects on the body.
• Alcohol: It is unsafe to consume alcohol when taking Pangraf 0.03% Ointment because it may cause the skin or face to become flushed or red and feel hot.
• Liver: Pangraf 0.03% Ointment should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary for severe liver failure. Inform your doctor if you have liver problems before initiating the therapy
• Lungs: It is unknown whether Pangraf 0.03% Ointment can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: It is unknown whether Pangraf 0.03% Ointment can impair the ability to drive. Consult your doctor for more advise.
• Pregnancy: Based on animal studies, Pangraf 0.03% Ointment can cause harmful effects on the baby. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant before initiating the treatment.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.